M
Mizuho Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
626
Acadia Pharmaceuticals
ACAD
$4.34B
|
VD
Vamil Divan
| $25.72 | $19 |
26%
downside
| Neutral | 3 years ago |
|
627
Neurocrine Biosciences
NBIX
$13.5B
|
VD
Vamil Divan
| $136.11 | $98 |
28%
downside
| Neutral | 3 years ago |
|
628
Alkermes
ALKS
$4.95B
|
VD
Vamil Divan
| $30 | $34 |
13%
upside
| Buy | 3 years ago |
|
629
Constellation Energy
CEG
$96.4B
|
PF
Paul Fremont
| $308.48 | $54 |
82%
downside
| Neutral | 3 years ago |
|
630
Comstock Resources
CRK
$4.63B
|
VL
Vincent Lovaglio
| $15.81 | $21 |
33%
upside
| Buy | 3 years ago |
|
631
Range Resources
RRC
$8.18B
|
VL
Vincent Lovaglio
| $34.35 | $38 |
11%
upside
| Neutral | 3 years ago |
|
632
Entergy
ETR
$38.9B
|
PF
Paul Fremont
| $87.20 | $61.50 |
29%
downside
| Buy | 3 years ago |
|
633
Alexandria Real Estate Equities
ARE
$13.9B
|
VM
Vikram Malhorta
| $81.56 | $172 |
111%
upside
| Buy | 3 years ago |
|
634
Qorvo
QRVO
$8.42B
|
CC
Chris Carey
| $90.88 | $110 |
21%
upside
| Neutral | 3 years ago |
|
635
FirstEnergy
FE
$25.1B
|
PF
Paul Fremont
| $43.40 | $40 |
8%
downside
| Neutral | 3 years ago |
|
636
Black Hills Corp
BKH
$4.33B
|
PF
Paul Fremont
| $59.45 | $76 |
28%
upside
| Neutral | 3 years ago |
|
637
Axsome Therapeutics
AXSM
$6.09B
|
VD
Vamil Divan
| $122 | $49 |
60%
downside
| Buy | 3 years ago |
|
638
Eli Lilly
LLY
$661B
|
VD
Vamil Divan
| $737.83 | $356 |
52%
downside
| Buy | 3 years ago |
|
639
Southern Company
SO
$101B
|
PF
Paul Fremont
| $91.66 | $76 |
17%
downside
| Neutral | 3 years ago |
|
640
APA Corp
APA
$8.11B
|
PS
Paul Sankey
| $22.68 | $56 |
147%
upside
| Buy | 3 years ago |
|
641
Akebia Therapeutics
AKBA
$827M
|
DY
Difei Yang
| $3.12 | $2 |
36%
downside
| Neutral | 3 years ago |
|
642
American Electric Power
AEP
$58.8B
|
PF
Paul Fremont
| $110.03 | $104 |
5%
downside
| Buy | 3 years ago |
|
643
Ventas
VTR
$30.7B
|
VM
Vikram Malhotra
| $67.45 | $65 |
4%
downside
| Buy | 3 years ago |
|
644
Welltower
WELL
$112B
|
VM
Vikram Malhotra
| $167.43 | $96 |
43%
downside
| Buy | 3 years ago |
|
645
Xeris Biopharma Holdings
XERS
$1.27B
|
VD
Vamil Divan
| $7.84 | $6 |
23%
downside
| Buy | 3 years ago |
|
646
Biohaven
BHVN
$1.71B
|
VD
Vamil Divan
| $16.21 | $154 |
850%
upside
| Buy | 3 years ago |
|
647
CF Industries
CF
$13.7B
|
CP
Chris Parkinson
| $84.77 | $78 |
8%
downside
| Neutral | 3 years ago |
|
648
Phillips Edison & Co
PECO
$4.45B
|
VM
Vikram Malhotra
| $35.46 | $35 |
1%
downside
| Buy | 3 years ago |
|
649
AbbVie
ABBV
$374B
|
VD
Vamil Divan
| $211.86 | $166 |
22%
downside
| Buy | 3 years ago |
|
|
SAFE
650
Safehold
SAFE
$1.16B
|
VM
Vikram Malhotra
| $16.20 | $75 |
363%
upside
| Neutral | 3 years ago |
|